Vor Biopharma Inc.
VOR · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $160 | $191 | $50 | $82 |
| Short-Term Investments | $10 | $10 | $10 | $10 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $2 | $4 | $5 | $5 |
| Total Curr. Assets | $172 | $205 | $65 | $97 |
| Property Plant & Equip (Net) | $3 | $0 | $40 | $42 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $5 | $15 |
| Total NC Assets | $4 | $0 | $44 | $57 |
| Other Assets | $0 | $0 | $0 | -$10 |
| Total Assets | $176 | $205 | $109 | $143 |
| Liabilities | – | – | – | – |
| Payables | $1 | $1 | $4 | $2 |
| Short-Term Debt | $0 | $0 | $4 | $4 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $18 | $58 | $9 | $13 |
| Total Curr. Liab. | $19 | $59 | $17 | $19 |
| LT Debt | $3 | $0 | $27 | $28 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $2,380 | $1,652 | $0 | $0 |
| Total NC Liab. | $2,383 | $1,652 | $27 | $28 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $3 | $0 | $31 | $32 |
| Total Liabilities | $2,402 | $1,711 | $43 | $46 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$2,876 | -$2,063 | -$489 | -$457 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $650 | $557 | $556 | $554 |
| Total Equity | -$2,225 | -$1,506 | $66 | $97 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $176 | $205 | $109 | $143 |
| Net Debt | -$157 | -$191 | -$19 | -$50 |